Agendia
From Wikipedia, the free encyclopedia
| Agendia B.V.
<tr><td colspan="2" style="text-align:center; padding:16px 0 16px 0;"> | |
| Type | Besloten Vennootschap ("secluded partnership") |
|---|---|
| Founded | 2003 |
| Headquarters | Amsterdam, the Netherlands
<tr><th style="text-align:right; padding-right:0.75em;">Key people</th><td>Bernhard Sixt, CEO</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Industry</th><td>Medical services</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Products</th><td>MammaPrint, CupPrint DiscoverPrint</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Revenue</th><td>--</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Employees</th><td>36</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Slogan</th><td>It's in our genes to help</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Website</th><td>www.agendia.com</td></tr> |
Agendia B.V. (Amsterdam GENetic DIAgnostics) is an Amsterdam based company that performs gene expression analysis (microarray) based diagnostics. It was founded in 2003 by Netherlands Cancer Institute (NKI) researchers Laura van 't Veer and René Bernards and Bernhard Sixt.
Agendia's main products are MammaPrint and CupPrint.
